Dr. Gilbert Tang
@GilbertTangMD
Followers
11K
Following
14K
Media
1K
Statuses
6K
Interventional cardiac surgeon sharing the latest developments in transcatheter valve therapy; Leader; Educator. Editor-in-Chief #JACCCaseReports
New York
Joined June 2012
@JACCJournals @sarano_maurice Authors’ handles:.@azeemlatib.@CardioMDPhD.@AndreaScotti21.@jcecharte.@Antonellamillin.@lloretzdemar.@gkfram.@LaiLeoDr.@AbdelfattahMD.@mmartinezheart.@RobynBrydeMDOmar.@PCremerMD.@rcstarling.@JP_HFpEF.@StefanoByer.@AtsSakamo.@saengerevan.@Dr_P_Ollitrault.@TampakisKostas.
0
1
4
@JACCJournals @sarano_maurice Heart Failure and Cardiomyopathies. Obstructive Hypertrophic Cardiomyopathy and Aortic Stenosis With High Surgical Risk Clinical Cases in the Diagnosis of Cardiac Sarcoidosis Tacrolimus-Induced Thrombotic Microangiopathy in.
1
0
2
Welcome to our July 2 issue of #JACCCaseReports @JACCJournals! See our articles with links below. Full PDF here:. Video summary here:. Thank you our Associate Editor @sarano_maurice for his Editor’s Page:.
1
9
18
0
0
0
Welcome to @JACCJournals #JACCCaseReports our 3 new Associate Editors @AmitPawaleMD @MiChen__ @AdityaParikhMD and thank you @miteshbadiwalaMD @TheLADoctor @EileenOMearaMD for their outstanding contribution last year, transitioning now to Specialty Editors. We also like to
2
1
16
DON’T MISS THIS! Hosted by @SubodhVermaMD @UnityHealthTO. We are pleased to invite you and your colleagues to a Special Virtual Journal Club on "Delirium in Cardiac Surgery" featuring Drs Ali Hassan and Rakesh Arora. Chaired by Drs Malak Elbatarny, and Subodh Verma, this Journal
0
1
7
Amazing #NYValves2025 @crfheart ! Great to see my friends back here in NYC and witness so much new data! Congrats!!!.
What an unforgettable #NYValves2025! 🎉 With over 3,000 attendees from around the world, this year’s meeting was a celebration of innovation, collaboration, and cutting-edge science in structural heart care. 🫀✨. A huge thank you to our faculty, attendees, and supporters for
1
3
25
RT @crfheart: What an unforgettable #NYValves2025! 🎉 With over 3,000 attendees from around the world, this year’s meeting was a celebration….
0
12
0
Honored to present on behalf of EXPANDed Investigators at #NYV2025 the 1y echo core lab adjudicated outcomes of #MitraClip M-TEER in SMR pts with COAPT and non-COAPT like criteria: LVEF <20%, LVEDD >70mm, PASP >70mmHg. Similar procedural safety. 1y MR <=1+ 90% both groups!
4
7
33
RT @JACCJournals: Nationwide study (n=791,917) shows #GDMT for HF is underused & underdosed:.✅ 51.2% started on ≥1 GDMT.❌ Most stopped with….
0
20
0
What an honor and privilege to present the #Intrepid TF #TMVR #EFS 2y outcomes at #NYValves2025 on behalf of all the investigators. High risk pts 60% >=80yo, 70% NYHA 3/4, >50% prior HFH, ~50% prior ❤️surgery. 2Y: No disabling stroke, device☠️, reintervention. 100% MR
3
7
31
10y outcomes on S3 #TAVR vs SAVR in intermediate risk pts in P2A S3i is out #NYValves2025! @tnazifMD presented similar site reported ☠️ (~80% dead in 10y with mean age 80) and low reintervention (3 and 3.2%) between two groups among survivors. It gives us a good picture of the
1
22
81
Important finding on CT and fluoro showing 2nd TAV in Redo #TAVR were 100% underexpanded despite procedural optimization with pre and post dilatation. Time to rethink lifetime management strategy and consider #TAVR explant in low risk pts to avoid redo TAVR PPM ? @JACCJournals.
First study reporting valve frame expansion & geometry by MDCT and fluoroscopy of both index & second valve in patients undergoing redo-TAVR. Larger studies with longer follow-up are needed #JACCINT #TAVR #NYValves2025
3
13
45
RT @JACCJournals: First study reporting valve frame expansion & geometry by MDCT and fluoroscopy of both index & second valve in patients u….
0
22
0
RT @KrutarthKPandya: 2 year outcomes for #TMVR presented by @GilbertTangMD . #LateBreaking #NYValves2025 @crfheart. #CardioEd
https://t.co….
0
2
0
RT @mirvatalasnag: @crfheart #NYValves2025 .#LBCT.2-yr Outcomes Following.Transfemoral Transseptal Transcatheter Mitral Valve.Replacement:….
0
11
0